LEP and cardiomyopathy: Future research is required to understand the precise role of leptin directly in different cardiac cell types (e.g., cardiomyocytes, endothelial cells or fibroblasts), which may open up new avenues for the treatment of obesity- and diabetes-associated cardiomyopathy.